MSCI Inc (MSCI) - Total Liabilities

Latest as of December 2025: $8.36 Billion USD

Based on the latest financial reports, MSCI Inc (MSCI) has total liabilities worth $8.36 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MSCI Inc cash flow conversion to assess how effectively this company generates cash.

MSCI Inc - Total Liabilities Trend (2003–2025)

This chart illustrates how MSCI Inc's total liabilities have evolved over time, based on quarterly financial data. Check MSCI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

MSCI Inc Competitors by Total Liabilities

The table below lists competitors of MSCI Inc ranked by their total liabilities.

Company Country Total Liabilities
Rocket Lab USA Inc.
NASDAQ:RKLB
USA $602.62 Million
China Hongqiao Group Ltd
F:H0Q
Germany €112.14 Billion
Waste Connections Inc
TO:WCN
Canada CA$12.88 Billion
Garmin Ltd
F:GEY
Germany €2.04 Billion
Legrand SA
PA:LR
France €9.69 Billion
Mahindra & Mahindra Limited
NSE:M&M
India Rs1.95 Trillion
Lumentum Holdings Inc
NASDAQ:LITE
USA $3.96 Billion
Accton Technology Corp
TW:2345
Taiwan NT$88.09 Billion

Liability Composition Analysis (2003–2025)

This chart breaks down MSCI Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MSCI stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -3.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MSCI Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MSCI Inc (2003–2025)

The table below shows the annual total liabilities of MSCI Inc from 2003 to 2025.

Year Total Liabilities Change
2025-12-31 $8.36 Billion +30.88%
2024-12-31 $6.39 Billion +2.04%
2023-12-31 $6.26 Billion +4.20%
2022-12-31 $6.01 Billion +5.91%
2021-12-31 $5.67 Billion +22.15%
2020-12-31 $4.64 Billion +8.43%
2019-12-31 $4.28 Billion +20.45%
2018-12-31 $3.55 Billion +23.65%
2017-12-31 $2.87 Billion +3.97%
2016-12-31 $2.76 Billion +23.13%
2015-12-31 $2.25 Billion +53.66%
2014-12-31 $1.46 Billion -6.21%
2013-12-31 $1.56 Billion -2.27%
2012-12-31 $1.59 Billion -10.81%
2011-12-31 $1.79 Billion -8.00%
2010-12-31 $1.94 Billion +180.30%
2009-12-31 $693.21 Million -4.87%
2008-12-31 $728.67 Million +3.41%
2007-12-31 $704.66 Million +145.47%
2006-12-31 $287.06 Million -1.12%
2005-12-31 $290.30 Million +235.70%
2003-12-31 $86.48 Million --

About MSCI Inc

NYSE:MSCI USA Financial Data & Stock Exchanges
Market Cap
$43.27 Billion
Market Cap Rank
#658 Global
#308 in USA
Share Price
$588.85
Change (1 day)
-0.43%
52-Week Range
$511.84 - $624.75
All Time High
$653.94
About

MSCI Inc., together with its subsidiaries, provides research-based data, analytics, and indexes, supported by advanced technology worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial products, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmark… Read more